Lemoyne wrote: I've been following consultas anvisa for a while and Teuto would fit the big generic pharma LABS most recently signed. Active (Caldic) and Collect have had products approved for years now, so for sure, they aren't the new pharma partner and the sales these two contracts resulted in are immaterial.
I still hope that verdemed could be dealing with medipharm, but it seems to be a pipe dream since I've learned about Teuto link to LABS:
-Verdemed is mentioned in 10+ products approved by anvisa, 4 of which are for Eurofarma.
-Verdemed doesn't seem to have shipped any of the products they have approvals for (20, 50, 100 and 200mg/ml concentration CBD in 30ml formats and other weird concentrations). That is since july 2023. Those concentrations fit LABS products. There doesn't seem to be 20, 100 and 200 CBD on brazilian websites. ->Eurofarma products supplied and approved for/by Verdemed cannot be found on brazilian pharmacy websites.
-Verdemed is registered as a CAD business on anvisa website, which would mean LABS would not appear on paperwork if it is supplying Verdemed in Canada. (Verdemed would be the one importing into brazil)
-Verdemed announcements weirdly coincide with LABS timeline in 2023
-Verdemed has received a new product approval in sept 2024, coinciding with LABS cc comments about brazil.
-Why woudl Verdemed products not make it to brazil since their approval in july 2023 (Verdemed) and Nov 2023 (Eurofarma). Was it because they were waiting for the last product to get approval for imports to start?
- Nothing would forbid LABS to sign Verdemed and Teuto.